| ABTS | 2,2′-Azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) |
| Ag-NPs | Silver nanoparticles |
| AMPK | Adenosine-monophosphate-activated protein kinase |
| ATCC | American-type culture collection |
| BHT | Butylated hydroxytoluene |
| COX-2 | Cyclooxygenase-2 |
| DMSO | Dimethylsulfoxide |
| DCM | Dichloromethane |
| DNA | Deoxyribonucleic acid |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| DW | Dried weight |
| EtOAc | Ethyl acetate |
| EtOH | Ethanol |
| GC-FID | Gas chromatography with flame ionisation detection |
| GC-MS | Gas chromatography coupled with mass spectrometry |
| GLUT-4 | Glucose transporter type 4 |
| H. L. Wendl. | Heinrich Ludolph (Ludwig) Wendlan |
| HPLC | High-performance liquid chromatography |
| HPLC-DAD | HPLC–photodiode array detection |
| HPLC-VWD | HPLC-variable wavelength detector |
| IBD | Inflammatory bowel diseases |
| IC50 | Half-maximal inhibitory concentration |
| IL-1b | Interleukin-1 |
| LDL | Low-density lipid |
| MBC | Minimum bactericidal concentration |
| MFC | Minimum fungicidal concentration |
| MIC | Minimum inhibition concentration |
| MOA | Mechanism of action |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide |
| NADH | Nicotinamide adenine dinucleotide H |
| NF-kB | Nuclear factor kappa B |
| NMR | Nuclear magnetic resonance |
| PGE2 | Prostaglandin E2 |
| PI3kt | phosphatidylinositol 3-kinase |
| Akt | serine/threonine kinase or serine/threonine kinase (PKB) |
| SAR | Structure-activity relationships |
| T2D | Type 2 diabetes |
| TEAC | Trolox equivalent antioxidant capacity |
| UC | Ulcerative colitis |
| VRE | Vancomycin-resistant enterococci |